Kayoko Murayama

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

Daisuke Ennishi, Yoshinobu Maeda, Nozomi Niitsu et al. · Blood · 2010 · 153 citations · Full text

Medicine, Hematology, Oncology +16

Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era

Hiroyuki Takahashi, Naoto Tomita, Masahiro Yokoyama et al. · Cancer · 2011 · 104 citations · Full text

Medicine, Internal Medicine, Oncology +14

Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era

Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto et al. · Cancer Science · 2011 · 88 citations

Medicine, Oncology, Cancer Immunology +9

Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases

Masaru Kojima, Hideaki Itoh, Kaoru Hirabayashi et al. · Pathology - Research and Practice · 2006 · 63 citations

Medicine, Hematology, Pathology +8

Clinical Implication of Idiopathic Plasmacytic Lymphadenopathy with Polyclonal Hypergammaglobulinemia: A Report of 16 Cases

Masaru Kojima, Shigeo Nakamura, Kazuhiko Shimizu et al. · International Journal of Surgical Pathology · 2004 · 34 citations

Medicine, Hematology, Pathology +17